4d pharma reveals 'phenomenal results' from early stage cancer trial - Duncan Peyton, CEO, 4D Pharma 00:00:00
4d pharma plc's (LON:DDDD) Duncan Peyton talks to the positive results of its clinical results in the first part of a trial on very poorly patients battling cancer.